On Monday, ZS Pharma Inc (NASDAQ:ZSPH)’s shares declined -0.25% to $76.80.
ZS Pharma, Inc. (ZSPH), confirmed that it has take partd in preliminary talk aboutions with Actelion Ltd. (ALIOF) regarding a potential planned transaction. ZS Pharma regularly and routinely explores opportunities with various planned partners and will continue to do so. These talk aboutions may or may not lead to any transaction. ZS Pharma does not intend to comment further on market speculation or disclose any developments unless and until it otherwise deems further disclosure is appropriate or required.
ZS Pharma, Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver, and metabolic diseases. The company’s proprietary zirconium silicate technology creates ion traps that could reduce toxic levels of specific electrolytes without disturbing the balance of other electrolytes. It is developing ZS-9, insoluble non-absorbed zirconium silicate that is in Phase III development for the treatment of hyperkalemia. The company was founded in 2008 and is headquartered in Coppell, Texas.
Banco Bilbao Vizcaya Argentaria SA (ADR) (NYSE:BBVA)’s shares dropped -1.01% to $8.78.
Destacame.cl, a Chilean startup that allows underbanked individuals to build a credit score based on their history of paying everyday bills, has won the BBVA Open Talent 2015 Special Financial Inclusion Award. The award, a new component of this year’s contest, is for startups that provide digital financial solutions to small businesses or low-income customers.
Launched in July 2015 by MIT graduates Jorge Camus and Sebastian Ugarte, Destacame.cl assists individuals without credit history who are unable to secure many financial services, like auto loans or mortgages. Destacame.cl uses a customer’s payment record for everyday bills, like electricity and gas, to build a credit profile. Data from the service is presently being used by three major Chilean financial institutions.
Banco Bilbao Vizcaya Argentaria, S.A. engages in the retail banking, wholesale banking, asset administration, and private banking businesses primarily in Spain, Eurasia, Mexico, South America, and the United States. It offers deposit products, counting personal accounts, housing accounts, savings accounts, deposit accounts, etc.; and loan products, such as personal loans, mortgages, etc.; credit cards; investment products comprising mutual funds, warrants, and pension plans; and telephone and on-line banking services, in addition to ATMs for individual customers.
At the end of Monday’s trade, Crestwood Midstream Partners LP (NYSE:CMLP)‘s shares dipped -4.30% to $6.46.
Crestwood Midstream Partners LP (CMLP) stated its financial and operating results for the three months ended June 30, 2015.
Second Quarter 2015 Highlights1
- Record Adjusted EBITDA of $125.4 million; a 14% enhance over $109.7 million in the second quarter 2014 driven by a 23% and 15% decrease in adjusted operating and administrative costs from the fourth quarter 2014 and first quarter 2015, respectively2
- Net Loss of $42.2 million, contrast to net income of $11.7 million in the second quarter 2014. Net loss for the second quarter 2015 comprises non-cash goodwill impairments of $40.2 million. These goodwill impairments were largely attributed to discount rate enhances resulting from continued commodity price volatility and the recent performance of CMLP’s unit price
- Improved operating margin to 77% in the second quarter 2015 contrast to 69% in fourth quarter 2014 reflecting Crestwood’s success in reducing operating and administrative costs to offset slightly lower volumes during the second quarter 20153
Crestwood Midstream Partners LP provides gathering, processing, storage, and transportation solutions to customers in the crude oil, natural gas liquids (NGL), and natural gas sectors of the energy industry in the United States. The company operates through three segments: Gathering and Processing, Storage and Transportation, and NGL and Crude Services. The Gathering and Processing segment provides natural gas gathering, processing, treating, compression, transportation, sale, and delivery services of NGLs to producers in unconventional shale plays and tight-gas plays in West Virginia, Wyoming, Texas, Arkansas, New Mexico, and Louisiana. This segment owns and controls natural gas facilities with about 2.5 billion cubic feet of natural gas/per day (Bcf/d) of gathering capacity; 481 million cubic feet of natural gas/per day of processing capacity; 1.1 Bcf/d of firm transmission capacity; and 41 Bcf of certified working gas storage capacity.
HCA Holdings Inc (NYSE:HCA), ended its Monday’s trading session with 0.35% gain, and closed at $84.98.
HCA Holdings, Inc. (HCA) is planned to present at the Morgan Stanley Global Healthcare Conference held at the Grand Hyatt New York, New York, NYon September 17, 2015 at 10:00 a.m. (EDT).
HCA Holdings, Inc., through its auxiliaries, provides health care services in the United States. It operates general, acute care hospitals that offer medical and surgical services, counting inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
